Rep. Kevin Hern Sells Off Shares of STERIS plc (NYSE:STE)

Posted by Max Byerly on Sep 29th, 2026

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of STERIS plc (NYSE:STE). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in STERIS stock on September 15th. The trade occurred in the Representative’s “KEVIN HERN TRADITIONAL IRA” account.

Representative Kevin Hern also recently made the following trade(s):

Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
Sold $15,001 – $50,000 in shares of IQVIA (NYSE:IQV) on 9/14/2026.
Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.
Sold $15,001 – $50,000 in shares of Devon Energy (NYSE:DVN) on 9/14/2026.

STERIS Price Performance

STE opened at $211.02 on Tuesday. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44. The company’s 50 day simple moving average is $224.38 and its 200 day simple moving average is $218.45. The stock has a market capitalization of $20.57 billion, a PE ratio of 25.80 and a beta of 0.91. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.35 and a current ratio of 1.91.

STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 EPS for the quarter, topping the consensus estimate of $2.49 by $0.10. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. STERIS’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.34 earnings per share. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. As a group, sell-side analysts expect that STERIS plc will post 11.12 EPS for the current year.

STERIS Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Friday, September 4th were given a $0.69 dividend. This is a boost from STERIS’s previous quarterly dividend of $0.63. This represents a $2.76 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Friday, September 4th. STERIS’s dividend payout ratio is 33.74%.

Wall Street Analyst Weigh In

STE has been the topic of a number of research reports. Piper Sandler restated an “overweight” rating and issued a $275.00 price objective (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Wall Street Zen upgraded shares of STERIS from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. UBS Group decreased their price objective on shares of STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of STERIS in a research note on Monday, August 24th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, STERIS currently has an average rating of “Moderate Buy” and a consensus target price of $271.33.

Get Our Latest Stock Report on STE

Insider Activity at STERIS

In other news, Director Mohsen Sohi sold 4,058 shares of the company’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the completion of the transaction, the director directly owned 24,305 shares of the company’s stock, valued at approximately $5,730,632.90. This represents a 14.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.12% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Wellington Management Group LLP lifted its position in shares of STERIS by 21.9% in the 2nd quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider’s stock worth $737,605,000 after buying an additional 629,532 shares during the last quarter. Geode Capital Management LLC grew its position in shares of STERIS by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 2,523,620 shares of the medical equipment provider’s stock valued at $637,259,000 after buying an additional 14,151 shares during the last quarter. Janus Henderson Group PLC raised its stake in STERIS by 25.7% during the first quarter. Janus Henderson Group PLC now owns 1,863,139 shares of the medical equipment provider’s stock worth $411,995,000 after acquiring an additional 380,504 shares during the period. Norges Bank bought a new position in STERIS in the fourth quarter worth about $320,298,000. Finally, Franklin Resources Inc. lifted its holdings in STERIS by 0.6% in the fourth quarter. Franklin Resources Inc. now owns 1,252,844 shares of the medical equipment provider’s stock worth $317,621,000 after acquiring an additional 7,840 shares during the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About STERIS

(Get Free Report)

STERIS plc (NYSE: STE) is a global provider of products and services designed to support infection prevention, sterilization, surgical procedures and other critical healthcare and life sciences activities. The company serves hospitals, ambulatory surgery centers, dental practices, pharmaceutical and biotechnology manufacturers, medical device companies, and research organizations.

Its offerings include sterilizers, washers, surgical tables and lights, operating-room equipment, endoscopy products, infection-prevention consumables, and related maintenance and technical services.